Clinical research

MISAGO 1: first-in-man clinical trial with Misago™ nitinol stent

EuroIntervention 2010;5:687-691 - DOI10.4244/EIJV5I6A113.

K Schulte
Karl-Ludwig Schulte1*, MD, PhD; Stefan Müller-Hülsbeck2, MD, PhD; Piergiorgio Cao3, MD, PhD; Jean-Pierre Becquemin4, MD, PhD; Ralf Langhoff1, MD; Nikolas Charalambous5, MD; Pascal Desgranges4, MD, PhD; Hicham Kobeiter4, MD; Marco Midulla6, MD; Vladimir Borovicanin7, MD; Dragica Paunovic7, MD; Jean-Paul Beregi6, MD, PhD
1. Vascular Center Berlin /Dept. Internal Medicine, Ev. Hospital Königin Elisabeth Herzberge, Berlin, Germany; 2. Department of Radiology, UKSH-Campus Kiel, currently-Academic Hospital Flensburg, Flensburg, Germany; 3. Vascular Surgery, University of Peru

Aims: To evaluate a newly developed self-expanding Misago™ (Terumo Corp., Tokyo, Japan) nitinol stent with rapid exchange delivery catheter for the treatment of stenotic or occluded superfi

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

peripheral obstructive diseasecritical limb diseaseangioplasty
Read next article
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

Latest news